Cargando…

Genomic profiling and prognostic factors of H3 K27M‐mutant spinal cord diffuse glioma

H3 K27‐altered diffuse midline glioma is a highly lethal pediatric‐type tumor without efficacious treatments. Recent findings have highlighted the heterogeneity among diffuse midline gliomas with different locations and ages. Compared to tumors located in the brain stem and thalamus, the molecular a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Rui‐Chao, Yan, Hao, An, Song‐Yuan, Pang, Bo, Chen, Hui‐Yuan, Mu, Quan‐Hua, Zhang, Ke‐Nan, Zhang, Yao‐Wu, Liu, Yu‐Qing, Liu, Xing, Zhao, Zheng, Jiang, Tao, Wang, Yong‐Zhi, Jia, Wen‐Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307522/ https://www.ncbi.nlm.nih.gov/pubmed/36751054 http://dx.doi.org/10.1111/bpa.13153

Ejemplares similares

The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation
por: Chai, Rui-Chao, et al.
Publicado: (2020)

Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient
por: Cheng, Ran, et al.
Publicado: (2021)

HGG-50. TWO CASES OF H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA OF CERVICAL SPINAL CORD
por: Kuroha, Masae, et al.
Publicado: (2020)

A validated prognostic nomogram for patients with H3 K27M-mutant diffuse midline glioma
por: Peng, Youheng, et al.
Publicado: (2023)

Spinal Cord Diffuse Midline Glioma, H3K27M- mutant Effectively Treated with Bevacizumab: A Report of Two Cases
por: YABUNO, Satoru, et al.
Publicado: (2021)

Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord
por: Gu, Quanquan, et al.
Publicado: (2021)

Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma
por: Gong, Xuan, et al.
Publicado: (2023)

Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma
por: Parsels, Leslie A., et al.
Publicado: (2023)

Radiotherapy and radio‐sensitization in H3 (K27M) ‐mutated diffuse midline gliomas
por: Liu, Chao, et al.
Publicado: (2023)

Absence of MGMT promoter methylation in diffuse midline glioma, H3 K27M-mutant
por: Banan, Rouzbeh, et al.
Publicado: (2017)

H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival
por: Chia, Noel, et al.
Publicado: (2021)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
por: Huang, Bowen, et al.
Publicado: (2023)

STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma
por: Anderson, Jacob B., et al.
Publicado: (2023)

Adult spinal cord diffuse midline glioma, H3 K27-altered mimics symptoms of central nervous system infection: a case report
por: Chen, Xue, et al.
Publicado: (2023)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
por: Zhao, Ji-ping, et al.
Publicado: (2022)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas
por: Abe, Hideaki, et al.
Publicado: (2020)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
por: Wingerter, Arthur, et al.
Publicado: (2021)

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
por: Schulte, Jessica D, et al.
Publicado: (2020)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
por: Gojo, Johannes, et al.
Publicado: (2020)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
por: Argersinger, Davis P., et al.
Publicado: (2021)

A rare case of adult diffuse midline glioma with H3 K27M mutant in the prepontine cistern
por: Chen, Xueling, et al.
Publicado: (2021)

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma
por: Zhang, Liang, et al.
Publicado: (2022)

Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline glioma
por: Peterson, Erik R., et al.
Publicado: (2023)

HGG-45. Characterization of spinal diffuse midline gliomas, H3 K28M-mutant
por: Stegat, Lotte, et al.
Publicado: (2022)

Deep learning‐based prediction of H3K27M alteration in diffuse midline gliomas based on whole‐brain MRI
por: Huang, Bowen, et al.
Publicado: (2023)

Diffuse midline glioma in the spinal cord with rapid respiratory deterioration
por: Kamidani, Ryo, et al.
Publicado: (2020)

Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma
por: Hohm, Annika, et al.
Publicado: (2021)

HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA
por: Paret, Claudia, et al.
Publicado: (2021)

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation
por: El Malki, Khalifa, et al.
Publicado: (2023)

Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature
por: Kraus, Theo F. J., et al.
Publicado: (2020)

Genomic Landscape of Intramedullary Spinal Cord Gliomas
por: Zhang, Ming, et al.
Publicado: (2019)

Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma
por: Sun, Yu, et al.
Publicado: (2019)

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
por: Maeda, Sachi, et al.
Publicado: (2020)

DIPG-16. ACUTE VERSUS PROLONGED CONVECTION-ENHANCED DELIVERY OF ALISERTIB INTO H3 K27M-MUTANT MODELS OF DIFFUSE MIDLINE GLIOMA
por: Rechberger, Julian S, et al.
Publicado: (2023)

HGG-33. Prognostic factors of H3K27M histone-mutant diffuse midline gliomas in patients ≤18yrs
por: Hu, Qingjun, et al.
Publicado: (2022)

Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children: A Retrospective Series of 164 Cases
por: Zheng, Linmao, et al.
Publicado: (2022)

K27M-mutant histone-3 as a novel target for glioma immunotherapy
por: Ochs, Katharina, et al.
Publicado: (2017)

The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
por: Liu, Ilon, et al.
Publicado: (2022)

Diffuse midline gliomas, H3 K27M-mutant are associated with less peritumoral edema and contrast enhancement in comparison to glioblastomas, H3 K27M-wildtype of midline structures
por: Banan, Rouzbeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gsls70860vv41b9t35s461chg0